Abstract
Familial Hypercholesterolemia (FH) is a hereditary disorder of lipoprotein metabolism, which has genetic basis not fully understood yet. In this sense, microRNAs (miRs), particularly those transported by exosomes, have emerged as a new and potential tool in the search for a better elucidation of the physiopathological mechanisms of FH and thus contribute to individualized therapy. Therefo…